Skip to main content

Aptevo Therapeutics Inc PRE 14A, filed Nov 12, 2026

Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Inc. will ask stockholders on December 14, 2026 to authorize warrant-related issuance equal to 20% or more of outstanding Common Stock or voting power, approve a 1-for-3 to 1-for-10 reverse split, and approve its Sixth Amended and Restated 2018 Stock Incentive Plan. AI summary

PRE 14A 2026-11-12 For: 2026-11-12
View Original
Added on November 13, 2026